- Conditions
- Gastro Intestinal Stromal Tumour, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Centre Antoine LACASSAGNE Nice, Alpes-Maritimes, France
- Hopital de La Timone Marseille, Bouches Du Rhône, France
- Institut Paoli Calmette Marseille, Bouches-du-Rhône, France
- Centre Georges-François Leclerc Dijon, Bourgogne-Franche-Comté, France
Clinical trial condition
Neoplastic Processes
Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.
3,270 public trials
686 recruiting studies
Neoplastic Processes trial results
Completed
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
NCT00547196
- Conditions
- Blast Crisis, Bone Marrow Diseases, Burkitt Lymphoma, +45 more
- Locations
-
- Banner Good Samaritan Medical Center Phoenix, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
NCT02049905
- Conditions
- Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma, Neoplasm Metastasis, Neoplasms, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Arizona Oncology Associates, PC Phoenix, Arizona, United States
- The University of Arizona Tucson, Arizona, United States
- City of Hope Medical Group Duarte, California, United States
Completed
The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma
NCT04860700
- Conditions
- Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Neoplasm Metastasis, +14 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT01619111
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Metastatic Breast Cancer, +10 more
- Locations
-
- University Hospital Ulm Ulm, Baden-Wurttemberg, Germany
NCT02035813
- Conditions
- Breast Diseases, Breast Neoplasms, HER2-negative Circulating Tumor Cells, +11 more
- Locations
-
- University Hospital Ulm -Department of Gynecology Ulm, Baden-Wurttemberg, Germany
Completed
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
NCT01514188
- Conditions
- Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma, Neoplasm Metastasis, +8 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
- Stanford University Stanford, California, United States
- University of Iowa Iowa City, Iowa, United States
- Pennsylvania Hematology Oncology Associates Philadelphia, Pennsylvania, United States
NCT02235701
- Conditions
- Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma, Neoplasm Metastasis, Neoplasms, +6 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
NCT02113657
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06424210
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +12 more
- Locations
-
- National Taiwan University Hospital Taipei, Zhongzheng, Taiwan